CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Astellas Pharma Inc. - 4503 CFD

1678.70
1.57%
Market Trading Hours* (UTC) Opens on Monday at 00:00

Mon - Fri: 00:00 - 02:30 03:30 - 06:00

  • Summary
  • Historical Data
Trading сonditions
Spread 13.20
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.011247 %
Charges from full value of position ($-2.14)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.011247%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.010976 %
Charges from full value of position ($-2.09)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.010976%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency JPY
Margin 5.00%
Stock exchange Japan
Commission on trade 0%

Key Stats
Prev. Close 1652.68
Open 1669.63
1-Year Change -19.37%
Day's Range 1665.24 - 1687.58
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 26, 2024 1690.67 18.05 1.08% 1672.62 1692.37 1658.66
Jul 25, 2024 1654.27 8.58 0.52% 1645.69 1664.25 1634.21
Jul 24, 2024 1653.67 8.58 0.52% 1645.09 1667.04 1637.21
Jul 23, 2024 1648.98 12.16 0.74% 1636.82 1650.98 1632.23
Jul 22, 2024 1628.34 -11.97 -0.73% 1640.31 1640.31 1613.27
Jul 19, 2024 1635.22 -16.36 -0.99% 1651.58 1654.87 1617.76
Jul 18, 2024 1690.08 14.47 0.86% 1675.61 1699.05 1671.11
Jul 17, 2024 1686.09 26.44 1.59% 1659.65 1692.87 1659.64
Jul 16, 2024 1644.09 -5.49 -0.33% 1649.58 1653.47 1636.61
Jul 12, 2024 1651.87 1.89 0.11% 1649.98 1659.26 1640.20
Jul 11, 2024 1656.76 15.95 0.97% 1640.81 1660.46 1635.61
Jul 10, 2024 1624.15 10.48 0.65% 1613.67 1627.54 1604.70
Jul 9, 2024 1625.85 22.15 1.38% 1603.70 1630.23 1599.70
Jul 8, 2024 1605.80 -14.56 -0.90% 1620.36 1627.44 1599.50
Jul 5, 2024 1610.38 3.49 0.22% 1606.89 1617.47 1599.81
Jul 4, 2024 1598.42 11.97 0.75% 1586.45 1600.41 1576.87
Jul 3, 2024 1585.45 6.59 0.42% 1578.86 1590.33 1577.37
Jul 2, 2024 1581.86 10.98 0.70% 1570.88 1587.05 1563.40
Jul 1, 2024 1580.86 -5.29 -0.33% 1586.15 1586.15 1560.41
Jun 28, 2024 1585.95 -13.96 -0.87% 1599.91 1604.40 1577.76

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Astellas Pharma Inc. Company profile

About Astellas Pharma Inc

Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Astellas Pharma Inc revenues increased 5% to Y992.29B. Net income applicable to common stockholders decreased less than 1% to Y132.49B. Revenues reflect Sales of Pharmaceuticals segment increase of 6% to Y971.11B, Other Business segment increase of 33% to Y14.07B, Americas segment increase of 15% to Y407.94B, Estabridge segment increase of 10% to Y239.22B.

Equity composition

04/2005, Company merged with Fujisawa Pharmaceutical Co., Ltd. & Name Changed from Yamanouchi Pharmaceutical Co., Ltd. FY'08 1Q&Q3 WAS & DWAS estimated and WAS used as O/S. FY'09 Q3,12 Q2 DWAS estimated.

Industry: Pharmaceuticals (NEC)

日本橋本町2-5-1
CHUO-KU
TOKYO-TO 103-8411
JP

People also watch

BTC/USD

68,006.70 Price
+4.100% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,387.21 Price
+0.940% 1D Chg, %
Long position overnight fee -0.0190%
Short position overnight fee 0.0108%
Overnight fee time 21:00 (UTC)
Spread 0.60

ETH/USD

3,280.77 Price
+3.990% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

US100

19,029.00 Price
+1.080% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading